CD40

CD40 詳細

英語名Tumor necrosis factor receptor superfamily member 5市販薬剤の数0
治験薬の数46ターゲットの別称Bp50,CD40 Antigens,CD40,B Cell Surface Antigen CD40,B-Cell Surface Antigen CD40,CDW40,CD40L Receptor,CD40 Molecule,Tumor Necrosis Factor Receptor Superfamily, Member 5,CD40 Molecule, TNF Receptor Superfamily Member 5,TNFRSF5,Tumor Necrosis Factor Receptor Superfamily Member 5,P50,CD40 Antigen,B Cell-Associated Molecule
研究&開発段階Phase 3 Clinical
英語名Tumor necrosis factor receptor superfamily member 5
ターゲットの別称Bp50,CD40 Antigens,CD40,B Cell Surface Antigen CD40,B-Cell Surface Antigen CD40,CDW40,CD40L Receptor,CD40 Molecule,Tumor Necrosis Factor Receptor Superfamily, Member 5,CD40 Molecule, TNF Receptor Superfamily Member 5,TNFRSF5,Tumor Necrosis Factor Receptor Superfamily Member 5,P50,CD40 Antigen,B Cell-Associated Molecule
市販薬剤の数0
治験薬の数46
研究&開発段階Phase 3 Clinical

CD40 製品リスト

  • 属性

    Protein (17)Cell (1)

  • 製品ライブラリ

    オンライン (18)

  • Human (8)Rhesus macaque (2)Mouse (4)Cynomolgus (1)Rabbit (1)Rat (1)Canine (1)

  • タグ

    Fc Tag (4)His Tag (8)His Tag & Avi Tag (2)Fc Tag & Avi Tag (2)Mouse IgG Fc Tag (1)- (1)

  • マーカー

    Unconjugated (12)Biotin-labeled (4)- (1)AF647 Labeled (1)

CD40バックグランド

CD40 is also known as TNFRSF5, Bp50, CDW40, MGC9013, TNFRSF5 and p50, is a member of the TNF receptor superfamily which are single transmembrane-spanning glycoproteins, and plays an essential role in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation. CD40 is a costimulatory protein found on antigen presenting cells and is required for their activation. The binding of CD154 (CD40L) on TH cells to CD40 activates antigen presenting cells and induces a variety of downstream effects. CD40 contains 4 cysteine-rich repeats in the extracellular domain, and is expressed in B cells, dendritic cells, macrophages, endothelial cells, and several tumor cell lines. The extracellular domain has the cysteinerich repeat regions, which are characteristic for many of the receptors of the TNF superfamily. Interaction of CD40 with its ligand, CD40L, leads to aggregation of CD40 molecules,which in turn interact with cytoplasmic components to initiate signaling pathways. Early studies on the CD40-CD40L system revealed its role in humoral immunity. Defects in CD40 result in hyper-IgM immunodeficiency type 3 (HIGM3), an autosomal recessive disorder characterized by an inability of B cells to undergo isotype switching, as well as an inability to mount an antibody-specific immune response, and a lack of germinal center formation.

CD40分子の別称

CD40,Bp50,CDW40,MGC9013,TNFRSF5,p50

ライセンシング

プロジェクト薬物タイプ治療分野適応症ステージエリア
CD40 mAbMonospecific antibodyOncology/CancerAdvanced solid tumorPhase IGlobal

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
MitazalimabADC-1013; JNJ-7107; JNJ-64457107Phase 3 ClinicalAlligator Bioscience AbBiliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Pancreatic Ductal; Neoplasms; Pancreatic Neoplasms; Solid tumours
詳細
CD40L-GVAXGM.CD40L; CD40L-GVAX; GM-CSF/CD40L; hCD40L/hGM-CSFPhase 2 ClinicalUniversity Of South FloridaAdenocarcinoma; Adenocarcinoma of Lung; Leukemia; Lung Neoplasms; Melanoma; Myelodysplastic Syndromes; Skin Melanoma
詳細
BI-655064BI-655064Phase 2 ClinicalC.H. Boehringer Sohn Ag & Co. KgArthritis, Rheumatoid; Lupus Nephritis; Purpura, Thrombocytopenic, Idiopathic
詳細
SotigalimabAPX-005M; EPI-0050; APX-005Phase 2 ClinicalEpitomics IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Esophageal Neoplasms; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Microsatellite Instability; Neoplasms; Pancreatic Neoplasms; Skin Melanoma; Skin Neoplasms; Stomach Neoplasms
詳細
IscalimabNVP-CFZ533; OM11-62-MF; CFZ-533Phase 2 ClinicalNovartis Pharma AgArthritis, Rheumatoid; Diabetes Mellitus, Type 1; Graves Disease; Hidradenitis Suppurativa; Lupus Erythematosus, Systemic; Lupus Nephritis; Myasthenia Gravis; Rejection of renal transplantation; Rejection of liver transplantation; Sjogren's Syndrome; Sjogren-Larsson Syndrome
詳細
Anti-CD40 ChiLob7/4 (BioNTech)Phase 2 ClinicalBiontech SeHead and Neck Neoplasms; Pancreatic Neoplasms
詳細
CDX-1140CDX-1140Phase 2 ClinicalCelldex TherapeuticsBile Duct Neoplasms; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melanoma; Metastatic breast cancer; Mouth Neoplasms; Nasopharyngeal Carcinoma; Oral Squamous Cell Carcinoma; Oropharyngeal Neoplasms; Oropharyngeal Squamous Cell Carcinoma (OPSCC); Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Uveal melanoma; Waldenstrom Macroglobulinemia
詳細
Bleselumab4D-11; ASKP-1240Phase 2 ClinicalKyowa Hakko Kogyo Co LtdGlomerulosclerosis, Focal Segmental; Psoriasis; Rejection of renal transplantation; Rejection of organ transplantation
詳細
TecaginlimabBNT-312; GEN-1042Phase 2 ClinicalGenmab A/SCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
MP-0317MP-0317Phase 2 ClinicalMolecular Partners AgBiliary Tract Neoplasms; Solid tumours
詳細
ABBV-9832ABBV-9832Phase 2 ClinicalAbbvie IncArthritis, Rheumatoid
詳細
RavagalimabABBV-323; PR-1629977Phase 2 ClinicalAbbvie IncColitis, Ulcerative; Sjogren's Syndrome
詳細
DFI-105DFI105; DFI-105Phase 2 ClinicalDiabetes Free IncDiabetes Mellitus, Type 2
詳細
SHR-2005SHR2005; SHR-2005Phase 2 ClinicalShanghai Hengrui Pharmaceutical Co LtdUrinary Bladder Neoplasms
詳細
SV-102SV-102; SV102; SYNC-T SV-102Phase 2 ClinicalSyncromune IncProstatic Neoplasms, Castration-Resistant
詳細
SHR-7367SHR7367; SHR-7367Phase 2 ClinicalShanghai Hengrui Pharmaceutical Co LtdNeoplasms; Solid tumours
詳細
CifurtilimabSEA-1C10; SEA-CD40Phase 2 ClinicalSeagen IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Hodgkin Disease; Lymphoma; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasm Metastasis; Neoplasms, Squamous Cell; Pancreatic Neoplasms; Squamous Cell Carcinoma of Head and Neck
詳細
TQB-2916TQB2916; TQB-2916Phase 2 ClinicalNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical GroupMelanoma; Neoplasms; Pancreatic Neoplasms; Sarcoma
詳細
MIL-97MIL-97Phase 2 ClinicalBeijing Mabworks Biotech Co LtdPancreatic Neoplasms; Solid tumours
詳細
DalnicastobartLVGN7409; LVGN-7409Phase 2 ClinicalLyvgen Biopharma(HK)LtdCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Head and Neck Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Papillomavirus Infections; Sarcoma; Solid tumours; Stomach Neoplasms; Uveal melanoma
詳細
OPT-101OPT-101Phase 2 ClinicalOp-T LLCDiabetes Mellitus, Type 1; Pneumonia; Sepsis
詳細
2141-V112141-V11Phase 2 ClinicalThe Rockefeller UniversityGanglioglioma; Glioblastoma; Glioma; Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Solid tumours; Urinary Bladder Neoplasms
詳細
CiltistotugYH003; YH-003Phase 2 ClinicalCarcinoma, Pancreatic Ductal; Melanoma; Pancreatic Neoplasms; Solid tumours
詳細
AbiprubartKPL-404Phase 2 ClinicalBeth Israel Deaconess Medical CenterArthritis, Rheumatoid; Sjogren's Syndrome
詳細
NJA-730NJA-730; NJA-730a; NJA-730bPhase 1 ClinicalNapajen PharmaAutoimmune Diseases
詳細
Autologous IL2 and CD40 ligand-expressing tumor cells (Baylor College of Medicine)Phase 1 ClinicalBaylor College Of MedicineLeukemia, Lymphocytic, Chronic, B-Cell
詳細
GiloralimabABBV-927Phase 1 ClinicalAbbvie IncCarcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
NG-350ANG-350APhase 1 ClinicalAkamis Bio LtdNeoplasm Metastasis; Neoplasms, Glandular and Epithelial; Rectal Neoplasms
詳細
SL-172154SL-172154; SIRPα -Fc-CD40LPhase 1 ClinicalShattuck Labs IncCarcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Ovarian Neoplasms; Peritoneal Neoplasms; Squamous Cell Carcinoma of Head and Neck
詳細
recombinant adenovirus vector vaccine targeting MUC1 (MicroVax)Phase 1 ClinicalMicrovax LlcNeoplasms
詳細
HIV ANTI-CD40.ENV GP140Phase 1 ClinicalLinKinVaxHIV Infections
詳細
PeptiCRAd-1Valo-D102; PeptiCRAd-1Phase 1 ClinicalValor BiotherapeuticsCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Liposarcoma, Myxoid; Neoplasms; Osteosarcoma; Sarcoma; Sarcoma, Synovial; Skin Melanoma; Triple Negative Breast Neoplasms
詳細
CD40xFAP bispecific antibody (Bristol-Myers Squibb Company)Phase 1 ClinicalBristol-Myers Squibb CompanySolid tumours
詳細
M-0324M-0324; M0324Phase 1 ClinicalMerck KGaA, Darmstadt, GermanyNeoplasms; Solid tumours
詳細
KK-2269KK-2269; KK2269Phase 1 ClinicalKyowa Kirin IncCarcinoma, Non-Small-Cell Lung; Esophageal adenocarcinoma; Gastroesophageal Junction Neoplasms; Solid tumours; Stomach Neoplasms
詳細
LNF-1901LNF-1901; LNF1901Phase 1 ClinicalLunan Pharmaceutical Group CoNeoplasms
詳細
B-901B-901; B901Phase 1 ClinicalFutureGen Biopharm (Beijing) Co LtdSolid tumours
詳細
SHR-1704SHR-1704Phase 1 ClinicalJiangsu Hengrui Medicine Co LtdNeoplasms
詳細
IMB-071703IMB-071703; IMB071703Phase 1 ClinicalBeijng Immunoah Pharma Tech Co LtdSolid tumours
詳細
ILB-2101ILB-2101Phase 1 ClinicalInnolake Biopharm (Hangzhou) Co LtdNeoplasms
詳細
HBM-9027HBM-9027; HBM9027Phase 1 ClinicalHarbour BiomedNeoplasms; Solid tumours
詳細
BSI-038BSI-038Phase 1 ClinicalBiosion IncSolid tumours
詳細
RO-7300490RO-7300490; RG-6189; FAP-CD40; FAP-huCD40Phase 1 ClinicalF. Hoffmann-La Roche LtdSolid tumours
詳細
InezetamabAMG-994Phase 1 ClinicalAmgen IncSolid tumours
詳細
BMS-986325Y 12XX-hz28-P238KPhase 1 ClinicalBristol-Myers Squibb CompanySjogren's Syndrome
詳細
NWY-001(Biocytogen Pharmaceuticals)NWY001(Biocytogen Pharmaceuticals); YH008; YH-008; NWY-001(Biocytogen Pharmaceuticals)Phase 1 ClinicalHematologic Neoplasms; Neoplasms; Solid tumours
詳細

レビュー

  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8